Stratec stock gained 0.89 percent as mwb cut its rating

Published on 09/28/2026 at 11:54 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Stratec stock's Q2 revenue reached EUR 59.11 million on June 30, 2026, while net income was EUR 4.162 million. The 2026 plan requires H2 sales of EUR 149 million to EUR 161 million.

Techniker montieren automatisiertes Diagnostik-Analysegerät in modernem Reinraum — Stratec SE (DE000STRA555) fertigt automatisierte Analysesysteme, hier ein Reinraum mit Laborrobotik im Einsatz, Illustration mit AI erstellt.

Stratec stock (ISIN DE000STRA555) stood at EUR 22.80 on Xetra on September 25, 2026 at 5:35 p.m. CET, up 0.89 percent for the session. The latest analyst move balances a clear Q2 recovery against demanding second-half execution targets.

Analysts raise the execution bar

mwb research cut Stratec from Hold to Sell on September 17, 2026, while keeping its price target at EUR 21.00. The report points to volatile customer ordering and says the recovery is already reflected in the valuation.

The target sits below the Xetra reference price of EUR 22.80, making the rating change a direct test of whether improving operations can outweigh execution risk. For investors, the central issue is delivery against the second-half plan rather than the Q2 rebound alone.

Q2 revenue returns to growth

Investing.com lists Q2/2026 revenue at EUR 59.11 million and net income at EUR 4.162 million for the period ending June 30, 2026. The revenue figure came with a forecast of EUR 60.30 million, putting actual sales EUR 1.19 million below that comparison value.

Operational profitability improved as well. Boersengefluester reported EBIT of EUR 5.57 million for Q2/2026, compared with EUR 2.25 million in the year-earlier period, and an EBIT margin of 9.40 percent.

Second half carries the outlook

The 2026 forecast now depends on second-half revenue of EUR 149 million to EUR 161 million, according to mwb research. That implies second-half growth of 12.00 percent to 22.00 percent against H2/2025, a demanding hurdle while customer demand remains volatile.

Boersengefluester reported that management targets currency-adjusted 2026 sales growth in the mid- to high-single-digit range and an adjusted EBIT margin near 10.00 percent, excluding restructuring costs. The contrast between that operating goal and the required H2 sales lift explains the cautious analyst stance.

Stratec stock holds a 22 euro level

Stratec's Xetra market capitalization was EUR 277.2 million on September 25, 2026, with 10,225 shares traded and a year-to-date performance of 3.17 percent. The stock's intraday range was EUR 22.35 to EUR 23.15, leaving the EUR 22.80 reference price inside that session band.